EveryLife submitted comments to FDA on Proposed Rule Involving Laboratory Developed Tests (LDTs) December 07, 2023 Share this page Comments to inform and make recommendations to the FDA on their Proposed Rule Involving Laboratory Developed Tests (LDTs) Genetic Testing Newborn Screening Diagnostic Odyssey Related Articles The EveryLife Foundation Submits Comments to Support Patient-Focused Drug Development and Medical Innovation July 01, 2026 The EveryLife Foundation Submits Comments in Response to Rep. Auchincloss' Request July 01, 2026 The EveryLife Foundation Submits Comments on the Impacts of PFDD Meetings July 01, 2026 See All News